Scientific Abstracts, Papers & Presentations
October 2011 |
| 2011 IATDMCT Congress |
| K. C. Kasper, A. Orozco, J. Nguyen, K. Chung, B. Moon and J. Valdez |
| Monitoring Methotrexate by ARK Immunoassay |
| K. C. Kasper, B. Moon, J. Nguyen, A. Orozco, K. Chung, J. Valencia and J. Valdez |
| Homogeneous Enzyme Immunoassay for HIV-1 Antiretroviral Drugs: Darunavir and Maraviroc |
July 2011 |
| 2011 AACC Annual Meeting |
| A. Orozco, J. Nguyen, B. Moon, K. Chung, J. Valencia, K.C. Kasper, J. Valdez |
| ARK Immunoassays for Methotrexate |
| J Murthy, M Boisclaire, N Kessimian. Department of Pathology and Laboratory Medicine, The Warren Alpert Medical School of Brown University. Department of Pathology, Memorial Hospital of RI, Pawtucket, Rhode Island. |
| Performance Charactersitcs of ARK Diagnostics Quantitative Immunoassay for Levetiracetam on The Beckman Random Access Unicel® Dxc System & Comparsion to LC-MS-MS Batch Analysis. |
December 2010 |
| Kasper KC, Moon B, Nguyen J, Valencia J, Chung K, Orozco A, Valdez J. |
| ARK Immunoassays for Antiepileptic Drugs: Gabapentin, Lamotrigine, Levetiracetam, Topiramate, Zonisamide |
| Poster 2.177, 2010 AES Annual Meeting, San Antonio, TX; Dec 2010. |
July 2010 |
| 2010 AACC Annual Meeting, Anaheim; July 2010. |
| Nguyen J, Moon B, Orozco A, Kasper KC, Valdez J. |
| Poster E-101: ARK Immunoassay for Gabapentin |
| Chung K, Orozco A, Valencia J, Moon B, Kasper KC, Valdez J. |
| Poster E-103: ARK Immunoassay for Lamotrigine |
| Abraham GJ, Gang H, Qureshi N. |
| Poster E-98: Application Of Levetiracetam (Keppra) Monitoring To Standard Laboratory Analyzers |
| Hardy E, Valdez J. |
| Poster E-110: ARK Topiramate Assay on The Ortho-Clinical Diagnostics Vitros® 5,1 FS Chemistry System |
October 2009 |
| Kasper KC, Moon B, Nguyen J, Valencia J, Chung K, Orozco A, Nguyen P, Valdez J. |
| ARK Homogeneous Enzyme Immunoassays for the Newer Antiepileptic Drugs. |
| Poster P-315, 2009 IATDMCT Biannual Meeting, Montreal, Canada; Oct 2009. |
October 2009 |
| Snozek CLH, Rollins LA, Peterson PW, Langman LJ. |
| Comparison of the ARK immunoassay to the Seradyn fluorescence polarization immunoassay for measurement of serum topiramate. |
| Abstract. Therapeutic Drug Monitoring. Oct 2009;31(5):610. Oral presentation. 2009 IATDMCT Biannual Meeting, Montreal, Canada; Oct 2009. |
September 2009 |
| Marin SJ, Juenke JM, Johnson-Davis KL, McMillin G |
| Validation of a New Immunoassay for the Quantification of Topiramate. |
| Abstract. Clinical Chemistry 55(6);Suppl Sept 2009:A252. E125 |
July 2009 |
| Marin SJ, Juenke JM, Johnson-Davis KL, McMillin G |
| Validation of a New Immunoassay for the Quantification of Topiramate. |
| Poster E-125, 2009 AACC Annual Meeting, Chicago; July 2009. |
July 2009 |
| Moon B, Nguyen J, Orozco A, Chung K, Kasper KC, Valdez J. |
| ARK Topiramate Assay on Roche/Hitachi 917 System. |
| Poster E-166, 2009 AACC Annual Meeting, Chicago; July 2009. |
January 2009 |
| Best BM, Letendre SL, Brigid E, Clifford DB, Collier AC, Gelman BB, McArthur JC, McCutchan JA, Simpson DM, Ellis R, Capparelli EV, Grant I, for the CHARTER Group. |
| Low atazanavir concentrations in cerebrospinal fluid. |
| Paper, AIDS 2009 Jan 2;23(1):83–87. |
July 2008 |
| Kasper KC, Valencia J, Chung K, Moon BS, Valdez J, Jayewardene A, Lizak P, and Aweeka FT. |
| Therapeutic Drug Monitoring for Efavirenz. |
| Poster, 2008 AACC Annual Meeting, Washington DC; July 2008. |
April 2007 |
| Cusato M, Villani P, Bartoli A, Broglia M, and Regazzi MB. |
| Comparison of an HPLC-UV method with a rapid automated immunoassay (EIA) to measure nevirapine concentration in HIV+ patients. |
| 8th International Workshop on Clinical Pharmacology of HIV Therapy, Budapest, Hungary, April 2007. |
April 2007 |
| Helms MK, Moon BS, Valdez JJ, Best B, Holland DT, Espina-Quinto R, Jauregui R, and Connor JD. |
| The ARK APV-Test: a rapid, automated immunoassay for amprenavir in human plasma. |
| Poster # 46, 8th International Workshop on Clinical Pharmacology of HIV Therapy, Budapest, Hungary, April 2007. |
April 2007 |
| Villani P, Cusato M, Bartoli A, Broglia M, and Regazzi MB. |
| Comparison of an HPLC-UV method with a rapid automated immunoassay (EIA) to measure atazanavir concentrations in HIV+ patients. |
| 8th International Workshop on Clinical Pharmacology of HIV Therapy, Budapest, Hungary, April 2007. |
September 2006 |
| Jayewardene A, Aweeka F, Moon B, DeLaurentis M, and Valdez J. |
| Rapid automated immunoassay for therapeutic drug monitoring of lopinavir: method evaluation and comparison to LC-MS-MS. |
| Presentation A379, 46th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), San Francisco, September 2006. |
August 2006 |
| Helms MK, Holland D, Espina-Quinto R, Stefanski E, Moon B, Valdez J, and Connor JD. |
| The ARK EFV-Test: a rapid, automated immunoassay for therapeutic drug monitoring of efavirenz. |
| Poster MOPE0146, XVI International AIDS Conference, Toronto, Canada; August 2006. |
April 2006 |
| Holland DT, Espina-Quinto R, Stefanski EK, Helms MK, Moon B, Valdez J, and Connor JD. |
| Rapid, automated immunoassay for atazanavir in plasma and cerebrospinal fluid (CSF) using ATV-TestTM: methods validation, application and comparison with HPLC plasma method. |
| Abstract #10, 7th International Workshop on Clinical Pharmacology of HIV Therapy, Lisbon, Portugal, April 2006. |
April 2006 |
| Helms M |
| Rapid, automated immunoassay for atazanavir in plasma and cerebrospinal fluid (CSF) using ATV-Test. |
| Presentation, 7th International Workshop on Clinical Pharmacology of HIV Therapy, Lisbon, Portugal, April 2006. |
April 2006 |
| Lam JT, Louie SG, Valdez JJ, Moon BS, Helms MK, Neely MN. |
| Novel atazanavir immunoassay. |
| Poster, 7th International Workshop on Clinical Pharmacology of HIV Therapy, Lisbon, Portugal; April 2006. |
February 2006 |
| Best B, Letendre S, Patel P, Clifford D, Collier A, Gelman B, McArthur J, McCutchan JA, Simpson D, Holland D, Grant I, Capparelli E, and the CHARTER Study Group. |
| Low atazanavir concentrations in cerebrospinal fluid. |
| Paper #576, 13th Conference on Retroviruses and Opportunistic Infections (CROI), Denver, February 2006. |
February 2006 |
| Best B, Letendre S, Patel P, Clifford D, Collier A, Gelman B, McArthurJ, McCutchan JA, Simpson D, Holland D, Grant I, Capparelli E, and the CHARTER Study Group. |
| Low atazanavir concentrations in cerebrospinal fluid. |
| Presentation, 13th Conference on Retroviruses and Opportunistic Infections (CROI), Denver, February 2006. |
December 2005 |
| Holland DT, Espina-Quinto R, Stefanski EK, Moon B, Valdez J, and Connor JD. |
| Rapid, automated immunoassay for therapeutic drug monitoring of nevirapine using ARK NVP-Test®: method validation, application and comparison with HPLC plasma method. |
| Poster, 45th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), Washington DC, December 2005. |
July 2005 |
| Holland DT, Espina-Quinto R, Stefanski EK, DeLaurentis M, Valdez J, and Connor JD. |
| Rapid automated immunoassay for therapeutic drug monitoring of lopinavir using ARK LPV-Test®: method validation, application and comparison with HPLC method. |
| Poster, 2005 AACC Annual Meeting, Orlando; July 2005. |
ARK Diagnostics is your source of choice for TDM assays.
Contact ARK Diagnostics today.
